Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Clinical trial NCT06184750 · RECRUITING

Trial details

NCT number: NCT06184750
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Atypical Ductal Hyperplasia Breast Atypical Lobular Hyperplasia Breast Carcinoma Breast Ductal Carcinoma In Situ Breast Lobular Carcinoma In Situ Estrogen Receptor-Positive Breast Carcinoma

Start date: 2024-09-27
Primary completion: 2028-03-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.